Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/28/2002 | WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
03/28/2002 | WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
03/28/2002 | WO2002024747A2 Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications |
03/28/2002 | WO2002024746A1 Transfer factor from birds eggs |
03/28/2002 | WO2002024744A2 49938, a human phospholipid transporter and uses therefor |
03/28/2002 | WO2002024743A2 55063, a human nmda family member and uses thereof |
03/28/2002 | WO2002024742A2 Atp-binding cassette protein |
03/28/2002 | WO2002024741A2 Isolated genomic polynucleotide fragments from chromosome 7 |
03/28/2002 | WO2002024739A2 Spas-1 cancer antigen |
03/28/2002 | WO2002024738A1 β-CATENIN NUCLEAR LOCALIZED PROTEIN |
03/28/2002 | WO2002024737A1 Nucleotide sequences which code for the dps gene of c. glutamicum |
03/28/2002 | WO2002024735A2 Peptide inhibitors of hiv entry |
03/28/2002 | WO2002024734A2 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nuclei c acid |
03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
03/28/2002 | WO2002024732A2 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) |
03/28/2002 | WO2002024731A2 Regulation of human fgd1-like protein |
03/28/2002 | WO2002024729A2 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use |
03/28/2002 | WO2002024728A2 Mammalian nuclear receptor cofactor cf6 and methods of use |
03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
03/28/2002 | WO2002024724A1 PREPARATION OF CAPPED mRNA |
03/28/2002 | WO2002024723A1 Modified factor viii |
03/28/2002 | WO2002024722A2 Crystalline fgf9 dimer and methods of use |
03/28/2002 | WO2002024721A1 21 human secreted proteins |
03/28/2002 | WO2002024719A1 21 human secreted proteins |
03/28/2002 | WO2002024718A1 Compositions and methods relating to prostate specific genes and proteins |
03/28/2002 | WO2002024640A2 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
03/28/2002 | WO2002024227A1 Tumor cell proliferation inhibitors |
03/28/2002 | WO2002024219A1 Growth factor complex |
03/28/2002 | WO2002024151A2 A method of use of sonic hedgehog protein as a ligand for patched |
03/28/2002 | WO2002024149A2 Immunogen comprising ligand bound hiv envelpe protein |
03/28/2002 | WO2002024142A2 Use of adenosine receptor modulators for regulating the function of netrines and/or of their receptors |
03/28/2002 | WO2002024057A2 Compositions and methods for the therapy and diagnosis of lung cancer |
03/28/2002 | WO2002011743A3 Treatment of prostate cancer |
03/28/2002 | WO2002004624A9 Novel g protein-coupled receptor protein and dna thereof |
03/28/2002 | WO2002004484A3 Hcv mosaic antigen composition |
03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
03/28/2002 | WO2001096530A8 Dimeric streptavidins |
03/28/2002 | WO2001094952A3 Methods and compositions for modulating oxidized ldl transport |
03/28/2002 | WO2001090144A3 Vip-related peptides for the treatment of sexual disorders in women |
03/28/2002 | WO2001090128A3 Haplotypes of the gpr3 gene |
03/28/2002 | WO2001090122A3 Haplotypes of the ctla4 gene |
03/28/2002 | WO2001089454A3 Proteus mirabilis-based vaccine |
03/28/2002 | WO2001088091A3 Novel bone marrow nucleic acids and polypeptides |
03/28/2002 | WO2001087939A3 Genes required for natural competence, proteins, and their use |
03/28/2002 | WO2001085964A3 Over expression of the whn protein |
03/28/2002 | WO2001085904A3 A novel polypeptide--- a human protein 9 containing the fragment of prion characteristic sequence and polynucleotide encoding it |
03/28/2002 | WO2001085781A3 Repair of nerve damage |
03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
03/28/2002 | WO2001085770A3 Sentinel virus ii |
03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
03/28/2002 | WO2001083686A3 Novel polypeptide, a human inclusion-like protein 9 and polynucleotide encoding it |
03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
03/28/2002 | WO2001081570A3 Heteromultimeric ion channel receptor and uses thereof |
03/28/2002 | WO2001081410A3 G protein-coupled receptors |
03/28/2002 | WO2001079522A3 Screening assay methods and systems using target pooling |
03/28/2002 | WO2001079497A3 33556, a human transporter and uses thereof |
03/28/2002 | WO2001079449A3 Novel nucleic acids and polypeptides |
03/28/2002 | WO2001079433A3 A novel polypeptide, a human cell differentiation transcription factor 13 and the polynucleotide encoding the polypeptide |
03/28/2002 | WO2001079424A3 A novel polypeptide - human mitochondrial atpase coupling facor 6-10 and the polynucleotide encoding said polypeptide |
03/28/2002 | WO2001078774A3 Recombinant intracellular pathogen vaccines and methods for use |
03/28/2002 | WO2001077286A3 A novel polypeptide, human uterine globine 58 and the polynucleotide encoding the polypeptide |
03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
03/28/2002 | WO2001075105A3 Human leucine-rich repeat family member and uses thereof |
03/28/2002 | WO2001075046A3 A novel polypeptide, mitotic cycle human regulation gene 17 and the polynucleotide encoding the polypeptide |
03/28/2002 | WO2001075045A3 A novel polypeptide - human clathrin light chain 17 and the polynucleotide encoding said polypeptide |
03/28/2002 | WO2001075036A3 A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide |
03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
03/28/2002 | WO2001073026A3 43238, a novel g protein-coupled receptor and uses therefor |
03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
03/28/2002 | WO2001070778A3 Maize glycine rich protein promoter and use thereof |
03/28/2002 | WO2001070777A3 Leafy cotyledon2 genes and their uses |
03/28/2002 | WO2001070774B1 Human t cell response to mhc-binding motif clusters |
03/28/2002 | WO2001068839A3 Regulation of human lipoxin a4 receptor-like protein |
03/28/2002 | WO2001066751A3 G protein-coupled receptors |
03/28/2002 | WO2001066596A3 Human fgf-23 gene and gene expression products |
03/28/2002 | WO2001064736A3 Proliferation arrest transcription factor and its use |
03/28/2002 | WO2001064714A3 Compounds and methods for modulating cell-adhesion mediated drug resistance |
03/28/2002 | WO2001063296A3 Method for carrying out the differential diagnostic determination of autoantibodies formed against the tsh receptor in a serum sample or plasma sample of a patient |
03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
03/28/2002 | WO2001062791A3 Control of tgf (beta) signaling by km23 superfamily members |
03/28/2002 | WO2001061021A3 Transgenic plants having resistance to a fungal disease |
03/28/2002 | WO2001060973A3 C/ebpbeta isoforms and methods of use in cell regulation and anti-tumorigenesis |
03/28/2002 | WO2001060864A3 Human ion channels |
03/28/2002 | WO2001057182A3 Nucleic acids, proteins, and antibodies |
03/28/2002 | WO2001055330A3 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
03/28/2002 | WO2001051642A3 Dna modification proteins |
03/28/2002 | WO2001049729A3 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
03/28/2002 | WO2001046227A3 'dispatched' polypeptides |
03/28/2002 | WO2001044177A3 Somatostatin analogs, radiolabelled derivatives thereof and their use |
03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
03/28/2002 | WO2001025267A3 Improved ricin-like toxins for treatment of cancer |
03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
03/28/2002 | WO2000061611A9 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
03/28/2002 | WO2000048621A9 Methods and compositions for regulating protein-protein interactions |
03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
03/28/2002 | WO2000043791A9 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |